The global Anti-erectile Dysfunction (ED) Drugs market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Anti-erectile Dysfunction (ED) Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Anti-erectile Dysfunction (ED) Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Anti-erectile Dysfunction (ED) Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Anti-erectile Dysfunction (ED) Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Anti-erectile Dysfunction (ED) Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Anti-erectile Dysfunction (ED) Drugs sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Anti-erectile Dysfunction (ED) Drugs Market Report

Report Metric	Details
Report Name	Anti-erectile Dysfunction (ED) Drugs Market
CAGR	5%
Segment by Type	Sildenafil (Viagra) Vardenafil (Levitra, Staxyn) Tadalafil (Cialis) Avanafil (Stendra) Udenafil (Zydena) Others
Segment by Application	Hospital Retail Pharmacy Clinic Online Pharmacy
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Bayer, Hims, Menarini Group, Lupin, Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, General Factory, CSBio, Dong-A ST, Metuchen Pharma, Seoul Pharma, Teva Pharma, S.K. Chemicals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Anti-erectile Dysfunction (ED) Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Anti-erectile Dysfunction (ED) Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-erectile Dysfunction (ED) Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Anti-erectile Dysfunction (ED) Drugs Market report?

Ans: The main players in the Anti-erectile Dysfunction (ED) Drugs Market are Pfizer, Bayer, Hims, Menarini Group, Lupin, Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, General Factory, CSBio, Dong-A ST, Metuchen Pharma, Seoul Pharma, Teva Pharma, S.K. Chemicals

What are the Application segmentation covered in the Anti-erectile Dysfunction (ED) Drugs Market report?

Ans: The Applications covered in the Anti-erectile Dysfunction (ED) Drugs Market report are Hospital, Retail Pharmacy, Clinic, Online Pharmacy

What are the Type segmentation covered in the Anti-erectile Dysfunction (ED) Drugs Market report?

Ans: The Types covered in the Anti-erectile Dysfunction (ED) Drugs Market report are Sildenafil (Viagra), Vardenafil (Levitra, Staxyn), Tadalafil (Cialis), Avanafil (Stendra), Udenafil (Zydena), Others

1 Study Coverage

1.1 Anti-erectile Dysfunction (ED) Drugs Product Introduction

1.2 Market by Type

1.2.1 Global Anti-erectile Dysfunction (ED) Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Sildenafil (Viagra)

1.2.3 Vardenafil (Levitra, Staxyn)

1.2.4 Tadalafil (Cialis)

1.2.5 Avanafil (Stendra)

1.2.6 Udenafil (Zydena)

1.2.7 Others

1.3 Market by Application

1.3.1 Global Anti-erectile Dysfunction (ED) Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Retail Pharmacy

1.3.4 Clinic

1.3.5 Online Pharmacy

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Anti-erectile Dysfunction (ED) Drugs Sales Estimates and Forecasts 2019-2030

2.2 Global Anti-erectile Dysfunction (ED) Drugs Revenue by Region

2.2.1 Global Anti-erectile Dysfunction (ED) Drugs Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Anti-erectile Dysfunction (ED) Drugs Revenue by Region (2019-2024)

2.2.3 Global Anti-erectile Dysfunction (ED) Drugs Revenue by Region (2025-2030)

2.2.4 Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Region (2019-2030)

2.3 Global Anti-erectile Dysfunction (ED) Drugs Sales Estimates and Forecasts 2019-2030

2.4 Global Anti-erectile Dysfunction (ED) Drugs Sales by Region

2.4.1 Global Anti-erectile Dysfunction (ED) Drugs Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Anti-erectile Dysfunction (ED) Drugs Sales by Region (2019-2024)

2.4.3 Global Anti-erectile Dysfunction (ED) Drugs Sales by Region (2025-2030)

2.4.4 Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Anti-erectile Dysfunction (ED) Drugs Sales by Manufacturers

3.1.1 Global Anti-erectile Dysfunction (ED) Drugs Sales by Manufacturers (2019-2024)

3.1.2 Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-erectile Dysfunction (ED) Drugs in 2023

3.2 Global Anti-erectile Dysfunction (ED) Drugs Revenue by Manufacturers

3.2.1 Global Anti-erectile Dysfunction (ED) Drugs Revenue by Manufacturers (2019-2024)

3.2.2 Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Anti-erectile Dysfunction (ED) Drugs Revenue in 2023

3.3 Global Key Players of Anti-erectile Dysfunction (ED) Drugs, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Anti-erectile Dysfunction (ED) Drugs Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Anti-erectile Dysfunction (ED) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Anti-erectile Dysfunction (ED) Drugs, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Anti-erectile Dysfunction (ED) Drugs, Product Offered and Application

3.8 Global Key Manufacturers of Anti-erectile Dysfunction (ED) Drugs, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Anti-erectile Dysfunction (ED) Drugs Sales by Type

4.1.1 Global Anti-erectile Dysfunction (ED) Drugs Historical Sales by Type (2019-2024)

4.1.2 Global Anti-erectile Dysfunction (ED) Drugs Forecasted Sales by Type (2025-2030)

4.1.3 Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Type (2019-2030)

4.2 Global Anti-erectile Dysfunction (ED) Drugs Revenue by Type

4.2.1 Global Anti-erectile Dysfunction (ED) Drugs Historical Revenue by Type (2019-2024)

4.2.2 Global Anti-erectile Dysfunction (ED) Drugs Forecasted Revenue by Type (2025-2030)

4.2.3 Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Type (2019-2030)

4.3 Global Anti-erectile Dysfunction (ED) Drugs Price by Type

4.3.1 Global Anti-erectile Dysfunction (ED) Drugs Price by Type (2019-2024)

4.3.2 Global Anti-erectile Dysfunction (ED) Drugs Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Anti-erectile Dysfunction (ED) Drugs Sales by Application

5.1.1 Global Anti-erectile Dysfunction (ED) Drugs Historical Sales by Application (2019-2024)

5.1.2 Global Anti-erectile Dysfunction (ED) Drugs Forecasted Sales by Application (2025-2030)

5.1.3 Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Application (2019-2030)

5.2 Global Anti-erectile Dysfunction (ED) Drugs Revenue by Application

5.2.1 Global Anti-erectile Dysfunction (ED) Drugs Historical Revenue by Application (2019-2024)

5.2.2 Global Anti-erectile Dysfunction (ED) Drugs Forecasted Revenue by Application (2025-2030)

5.2.3 Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Application (2019-2030)

5.3 Global Anti-erectile Dysfunction (ED) Drugs Price by Application

5.3.1 Global Anti-erectile Dysfunction (ED) Drugs Price by Application (2019-2024)

5.3.2 Global Anti-erectile Dysfunction (ED) Drugs Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Anti-erectile Dysfunction (ED) Drugs Market Size by Type

6.1.1 US & Canada Anti-erectile Dysfunction (ED) Drugs Sales by Type (2019-2030)

6.1.2 US & Canada Anti-erectile Dysfunction (ED) Drugs Revenue by Type (2019-2030)

6.2 US & Canada Anti-erectile Dysfunction (ED) Drugs Market Size by Application

6.2.1 US & Canada Anti-erectile Dysfunction (ED) Drugs Sales by Application (2019-2030)

6.2.2 US & Canada Anti-erectile Dysfunction (ED) Drugs Revenue by Application (2019-2030)

6.3 US & Canada Anti-erectile Dysfunction (ED) Drugs Market Size by Country

6.3.1 US & Canada Anti-erectile Dysfunction (ED) Drugs Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Anti-erectile Dysfunction (ED) Drugs Sales by Country (2019-2030)

6.3.3 US & Canada Anti-erectile Dysfunction (ED) Drugs Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Anti-erectile Dysfunction (ED) Drugs Market Size by Type

7.1.1 Europe Anti-erectile Dysfunction (ED) Drugs Sales by Type (2019-2030)

7.1.2 Europe Anti-erectile Dysfunction (ED) Drugs Revenue by Type (2019-2030)

7.2 Europe Anti-erectile Dysfunction (ED) Drugs Market Size by Application

7.2.1 Europe Anti-erectile Dysfunction (ED) Drugs Sales by Application (2019-2030)

7.2.2 Europe Anti-erectile Dysfunction (ED) Drugs Revenue by Application (2019-2030)

7.3 Europe Anti-erectile Dysfunction (ED) Drugs Market Size by Country

7.3.1 Europe Anti-erectile Dysfunction (ED) Drugs Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Anti-erectile Dysfunction (ED) Drugs Sales by Country (2019-2030)

7.3.3 Europe Anti-erectile Dysfunction (ED) Drugs Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Anti-erectile Dysfunction (ED) Drugs Market Size

8.1.1 China Anti-erectile Dysfunction (ED) Drugs Sales (2019-2030)

8.1.2 China Anti-erectile Dysfunction (ED) Drugs Revenue (2019-2030)

8.2 China Anti-erectile Dysfunction (ED) Drugs Market Size by Application

8.2.1 China Anti-erectile Dysfunction (ED) Drugs Sales by Application (2019-2030)

8.2.2 China Anti-erectile Dysfunction (ED) Drugs Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Anti-erectile Dysfunction (ED) Drugs Market Size by Type

9.1.1 Asia Anti-erectile Dysfunction (ED) Drugs Sales by Type (2019-2030)

9.1.2 Asia Anti-erectile Dysfunction (ED) Drugs Revenue by Type (2019-2030)

9.2 Asia Anti-erectile Dysfunction (ED) Drugs Market Size by Application

9.2.1 Asia Anti-erectile Dysfunction (ED) Drugs Sales by Application (2019-2030)

9.2.2 Asia Anti-erectile Dysfunction (ED) Drugs Revenue by Application (2019-2030)

9.3 Asia Anti-erectile Dysfunction (ED) Drugs Sales by Region

9.3.1 Asia Anti-erectile Dysfunction (ED) Drugs Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Anti-erectile Dysfunction (ED) Drugs Revenue by Region (2019-2030)

9.3.3 Asia Anti-erectile Dysfunction (ED) Drugs Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Anti-erectile Dysfunction (ED) Drugs Market Size by Type

10.1.1 Middle East, Africa and Latin America Anti-erectile Dysfunction (ED) Drugs Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Anti-erectile Dysfunction (ED) Drugs Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Anti-erectile Dysfunction (ED) Drugs Market Size by Application

10.2.1 Middle East, Africa and Latin America Anti-erectile Dysfunction (ED) Drugs Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Anti-erectile Dysfunction (ED) Drugs Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Anti-erectile Dysfunction (ED) Drugs Sales by Country

10.3.1 Middle East, Africa and Latin America Anti-erectile Dysfunction (ED) Drugs Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Anti-erectile Dysfunction (ED) Drugs Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Anti-erectile Dysfunction (ED) Drugs Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Vivus, Inc.

11.1.1 Vivus, Inc. Company Information

11.1.2 Vivus, Inc. Overview

11.1.3 Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Vivus, Inc. Recent Developments

11.2 Lilly ICOS LLC

11.2.1 Lilly ICOS LLC Company Information

11.2.2 Lilly ICOS LLC Overview

11.2.3 Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Lilly ICOS LLC Recent Developments

11.3 Pfizer

11.3.1 Pfizer Company Information

11.3.2 Pfizer Overview

11.3.3 Pfizer Anti-erectile Dysfunction (ED) Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Pfizer Anti-erectile Dysfunction (ED) Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Pfizer Recent Developments

11.4 Bayer

11.4.1 Bayer Company Information

11.4.2 Bayer Overview

11.4.3 Bayer Anti-erectile Dysfunction (ED) Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Bayer Anti-erectile Dysfunction (ED) Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Bayer Recent Developments

11.5 Hims

11.5.1 Hims Company Information

11.5.2 Hims Overview

11.5.3 Hims Anti-erectile Dysfunction (ED) Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Hims Anti-erectile Dysfunction (ED) Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Hims Recent Developments

11.6 Menarini Group

11.6.1 Menarini Group Company Information

11.6.2 Menarini Group Overview

11.6.3 Menarini Group Anti-erectile Dysfunction (ED) Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Menarini Group Anti-erectile Dysfunction (ED) Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Menarini Group Recent Developments

11.7 Lupin

11.7.1 Lupin Company Information

11.7.2 Lupin Overview

11.7.3 Lupin Anti-erectile Dysfunction (ED) Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Lupin Anti-erectile Dysfunction (ED) Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Lupin Recent Developments

11.8 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

11.8.1 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Company Information

11.8.2 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Overview

11.8.3 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Recent Developments

11.9 General Factory

11.9.1 General Factory Company Information

11.9.2 General Factory Overview

11.9.3 General Factory Anti-erectile Dysfunction (ED) Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.9.4 General Factory Anti-erectile Dysfunction (ED) Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 General Factory Recent Developments

11.10 CSBio

11.10.1 CSBio Company Information

11.10.2 CSBio Overview

11.10.3 CSBio Anti-erectile Dysfunction (ED) Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.10.4 CSBio Anti-erectile Dysfunction (ED) Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 CSBio Recent Developments

11.11 Dong-A ST

11.11.1 Dong-A ST Company Information

11.11.2 Dong-A ST Overview

11.11.3 Dong-A ST Anti-erectile Dysfunction (ED) Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.11.4 Dong-A ST Anti-erectile Dysfunction (ED) Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 Dong-A ST Recent Developments

11.12 Metuchen Pharma

11.12.1 Metuchen Pharma Company Information

11.12.2 Metuchen Pharma Overview

11.12.3 Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.12.4 Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.12.5 Metuchen Pharma Recent Developments

11.13 Seoul Pharma

11.13.1 Seoul Pharma Company Information

11.13.2 Seoul Pharma Overview

11.13.3 Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.13.4 Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.13.5 Seoul Pharma Recent Developments

11.14 Teva Pharma

11.14.1 Teva Pharma Company Information

11.14.2 Teva Pharma Overview

11.14.3 Teva Pharma Anti-erectile Dysfunction (ED) Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.14.4 Teva Pharma Anti-erectile Dysfunction (ED) Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.14.5 Teva Pharma Recent Developments

11.15 S.K. Chemicals

11.15.1 S.K. Chemicals Company Information

11.15.2 S.K. Chemicals Overview

11.15.3 S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.15.4 S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.15.5 S.K. Chemicals Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Anti-erectile Dysfunction (ED) Drugs Industry Chain Analysis

12.2 Anti-erectile Dysfunction (ED) Drugs Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Anti-erectile Dysfunction (ED) Drugs Production Mode & Process

12.4 Anti-erectile Dysfunction (ED) Drugs Sales and Marketing

12.4.1 Anti-erectile Dysfunction (ED) Drugs Sales Channels

12.4.2 Anti-erectile Dysfunction (ED) Drugs Distributors

12.5 Anti-erectile Dysfunction (ED) Drugs Customers

13 Market Dynamics

13.1 Anti-erectile Dysfunction (ED) Drugs Industry Trends

13.2 Anti-erectile Dysfunction (ED) Drugs Market Drivers

13.3 Anti-erectile Dysfunction (ED) Drugs Market Challenges

13.4 Anti-erectile Dysfunction (ED) Drugs Market Restraints

14 Key Findings in The Global Anti-erectile Dysfunction (ED) Drugs Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

List of Tables

Table 1. Global Anti-erectile Dysfunction (ED) Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Sildenafil (Viagra)

Table 3. Major Manufacturers of Vardenafil (Levitra, Staxyn)

Table 4. Major Manufacturers of Tadalafil (Cialis)

Table 5. Major Manufacturers of Avanafil (Stendra)

Table 6. Major Manufacturers of Udenafil (Zydena)

Table 7. Major Manufacturers of Others

Table 8. Global Anti-erectile Dysfunction (ED) Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 9. Global Anti-erectile Dysfunction (ED) Drugs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 10. Global Anti-erectile Dysfunction (ED) Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 11. Global Anti-erectile Dysfunction (ED) Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 12. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Region (2019-2024)

Table 13. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Region (2025-2030)

Table 14. Global Anti-erectile Dysfunction (ED) Drugs Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 15. Global Anti-erectile Dysfunction (ED) Drugs Sales by Region (2019-2024) & (K Units)

Table 16. Global Anti-erectile Dysfunction (ED) Drugs Sales by Region (2025-2030) & (K Units)

Table 17. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Region (2019-2024)

Table 18. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Region (2025-2030)

Table 19. Global Anti-erectile Dysfunction (ED) Drugs Sales by Manufacturers (2019-2024) & (K Units)

Table 20. Global Anti-erectile Dysfunction (ED) Drugs Sales Share by Manufacturers (2019-2024)

Table 21. Global Anti-erectile Dysfunction (ED) Drugs Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 22. Global Anti-erectile Dysfunction (ED) Drugs Revenue Share by Manufacturers (2019-2024)

Table 23. Global Key Players of Anti-erectile Dysfunction (ED) Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 24. Anti-erectile Dysfunction (ED) Drugs Price by Manufacturers 2019-2024 (US$/Unit)

Table 25. Global Anti-erectile Dysfunction (ED) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 26. Global Anti-erectile Dysfunction (ED) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-erectile Dysfunction (ED) Drugs as of 2023)

Table 27. Global Key Manufacturers of Anti-erectile Dysfunction (ED) Drugs, Manufacturing Base Distribution and Headquarters

Table 28. Global Key Manufacturers of Anti-erectile Dysfunction (ED) Drugs, Product Offered and Application

Table 29. Global Key Manufacturers of Anti-erectile Dysfunction (ED) Drugs, Date of Enter into This Industry

Table 30. Mergers & Acquisitions, Expansion Plans

Table 31. Global Anti-erectile Dysfunction (ED) Drugs Sales by Type (2019-2024) & (K Units)

Table 32. Global Anti-erectile Dysfunction (ED) Drugs Sales by Type (2025-2030) & (K Units)

Table 33. Global Anti-erectile Dysfunction (ED) Drugs Sales Share by Type (2019-2024)

Table 34. Global Anti-erectile Dysfunction (ED) Drugs Sales Share by Type (2025-2030)

Table 35. Global Anti-erectile Dysfunction (ED) Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 36. Global Anti-erectile Dysfunction (ED) Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 37. Global Anti-erectile Dysfunction (ED) Drugs Revenue Share by Type (2019-2024)

Table 38. Global Anti-erectile Dysfunction (ED) Drugs Revenue Share by Type (2025-2030)

Table 39. Anti-erectile Dysfunction (ED) Drugs Price by Type (2019-2024) & (US$/Unit)

Table 40. Global Anti-erectile Dysfunction (ED) Drugs Price Forecast by Type (2025-2030) & (US$/Unit)

Table 41. Global Anti-erectile Dysfunction (ED) Drugs Sales by Application (2019-2024) & (K Units)

Table 42. Global Anti-erectile Dysfunction (ED) Drugs Sales by Application (2025-2030) & (K Units)

Table 43. Global Anti-erectile Dysfunction (ED) Drugs Sales Share by Application (2019-2024)

Table 44. Global Anti-erectile Dysfunction (ED) Drugs Sales Share by Application (2025-2030)

Table 45. Global Anti-erectile Dysfunction (ED) Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 46. Global Anti-erectile Dysfunction (ED) Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 47. Global Anti-erectile Dysfunction (ED) Drugs Revenue Share by Application (2019-2024)

Table 48. Global Anti-erectile Dysfunction (ED) Drugs Revenue Share by Application (2025-2030)

Table 49. Anti-erectile Dysfunction (ED) Drugs Price by Application (2019-2024) & (US$/Unit)

Table 50. Global Anti-erectile Dysfunction (ED) Drugs Price Forecast by Application (2025-2030) & (US$/Unit)

Table 51. US & Canada Anti-erectile Dysfunction (ED) Drugs Sales by Type (2019-2024) & (K Units)

Table 52. US & Canada Anti-erectile Dysfunction (ED) Drugs Sales by Type (2025-2030) & (K Units)

Table 53. US & Canada Anti-erectile Dysfunction (ED) Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 54. US & Canada Anti-erectile Dysfunction (ED) Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 55. US & Canada Anti-erectile Dysfunction (ED) Drugs Sales by Application (2019-2024) & (K Units)

Table 56. US & Canada Anti-erectile Dysfunction (ED) Drugs Sales by Application (2025-2030) & (K Units)

Table 57. US & Canada Anti-erectile Dysfunction (ED) Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 58. US & Canada Anti-erectile Dysfunction (ED) Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 59. US & Canada Anti-erectile Dysfunction (ED) Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 60. US & Canada Anti-erectile Dysfunction (ED) Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 61. US & Canada Anti-erectile Dysfunction (ED) Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 62. US & Canada Anti-erectile Dysfunction (ED) Drugs Sales by Country (2019-2024) & (K Units)

Table 63. US & Canada Anti-erectile Dysfunction (ED) Drugs Sales by Country (2025-2030) & (K Units)

Table 64. Europe Anti-erectile Dysfunction (ED) Drugs Sales by Type (2019-2024) & (K Units)

Table 65. Europe Anti-erectile Dysfunction (ED) Drugs Sales by Type (2025-2030) & (K Units)

Table 66. Europe Anti-erectile Dysfunction (ED) Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 67. Europe Anti-erectile Dysfunction (ED) Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 68. Europe Anti-erectile Dysfunction (ED) Drugs Sales by Application (2019-2024) & (K Units)

Table 69. Europe Anti-erectile Dysfunction (ED) Drugs Sales by Application (2025-2030) & (K Units)

Table 70. Europe Anti-erectile Dysfunction (ED) Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 71. Europe Anti-erectile Dysfunction (ED) Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 72. Europe Anti-erectile Dysfunction (ED) Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 73. Europe Anti-erectile Dysfunction (ED) Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 74. Europe Anti-erectile Dysfunction (ED) Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 75. Europe Anti-erectile Dysfunction (ED) Drugs Sales by Country (2019-2024) & (K Units)

Table 76. Europe Anti-erectile Dysfunction (ED) Drugs Sales by Country (2025-2030) & (K Units)

Table 77. China Anti-erectile Dysfunction (ED) Drugs Sales by Type (2019-2024) & (K Units)

Table 78. China Anti-erectile Dysfunction (ED) Drugs Sales by Type (2025-2030) & (K Units)

Table 79. China Anti-erectile Dysfunction (ED) Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 80. China Anti-erectile Dysfunction (ED) Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 81. China Anti-erectile Dysfunction (ED) Drugs Sales by Application (2019-2024) & (K Units)

Table 82. China Anti-erectile Dysfunction (ED) Drugs Sales by Application (2025-2030) & (K Units)

Table 83. China Anti-erectile Dysfunction (ED) Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 84. China Anti-erectile Dysfunction (ED) Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 85. Asia Anti-erectile Dysfunction (ED) Drugs Sales by Type (2019-2024) & (K Units)

Table 86. Asia Anti-erectile Dysfunction (ED) Drugs Sales by Type (2025-2030) & (K Units)

Table 87. Asia Anti-erectile Dysfunction (ED) Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 88. Asia Anti-erectile Dysfunction (ED) Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 89. Asia Anti-erectile Dysfunction (ED) Drugs Sales by Application (2019-2024) & (K Units)

Table 90. Asia Anti-erectile Dysfunction (ED) Drugs Sales by Application (2025-2030) & (K Units)

Table 91. Asia Anti-erectile Dysfunction (ED) Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 92. Asia Anti-erectile Dysfunction (ED) Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 93. Asia Anti-erectile Dysfunction (ED) Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 94. Asia Anti-erectile Dysfunction (ED) Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 95. Asia Anti-erectile Dysfunction (ED) Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 96. Asia Anti-erectile Dysfunction (ED) Drugs Sales by Region (2019-2024) & (K Units)

Table 97. Asia Anti-erectile Dysfunction (ED) Drugs Sales by Region (2025-2030) & (K Units)

Table 98. Middle East, Africa and Latin America Anti-erectile Dysfunction (ED) Drugs Sales by Type (2019-2024) & (K Units)

Table 99. Middle East, Africa and Latin America Anti-erectile Dysfunction (ED) Drugs Sales by Type (2025-2030) & (K Units)

Table 100. Middle East, Africa and Latin America Anti-erectile Dysfunction (ED) Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Anti-erectile Dysfunction (ED) Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Anti-erectile Dysfunction (ED) Drugs Sales by Application (2019-2024) & (K Units)

Table 103. Middle East, Africa and Latin America Anti-erectile Dysfunction (ED) Drugs Sales by Application (2025-2030) & (K Units)

Table 104. Middle East, Africa and Latin America Anti-erectile Dysfunction (ED) Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 105. Middle East, Africa and Latin America Anti-erectile Dysfunction (ED) Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 106. Middle East, Africa and Latin America Anti-erectile Dysfunction (ED) Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 107. Middle East, Africa and Latin America Anti-erectile Dysfunction (ED) Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 108. Middle East, Africa and Latin America Anti-erectile Dysfunction (ED) Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 109. Middle East, Africa and Latin America Anti-erectile Dysfunction (ED) Drugs Sales by Country (2019-2024) & (K Units)

Table 110. Middle East, Africa and Latin America Anti-erectile Dysfunction (ED) Drugs Sales by Country (2025-2030) & (K Units)

Table 111. Vivus, Inc. Company Information

Table 112. Vivus, Inc. Description and Major Businesses

Table 113. Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 114. Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 115. Vivus, Inc. Recent Developments

Table 116. Lilly ICOS LLC Company Information

Table 117. Lilly ICOS LLC Description and Major Businesses

Table 118. Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 119. Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 120. Lilly ICOS LLC Recent Developments

Table 121. Pfizer Company Information

Table 122. Pfizer Description and Major Businesses

Table 123. Pfizer Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 124. Pfizer Anti-erectile Dysfunction (ED) Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 125. Pfizer Recent Developments

Table 126. Bayer Company Information

Table 127. Bayer Description and Major Businesses

Table 128. Bayer Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 129. Bayer Anti-erectile Dysfunction (ED) Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 130. Bayer Recent Developments

Table 131. Hims Company Information

Table 132. Hims Description and Major Businesses

Table 133. Hims Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 134. Hims Anti-erectile Dysfunction (ED) Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 135. Hims Recent Developments

Table 136. Menarini Group Company Information

Table 137. Menarini Group Description and Major Businesses

Table 138. Menarini Group Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 139. Menarini Group Anti-erectile Dysfunction (ED) Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 140. Menarini Group Recent Developments

Table 141. Lupin Company Information

Table 142. Lupin Description and Major Businesses

Table 143. Lupin Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 144. Lupin Anti-erectile Dysfunction (ED) Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 145. Lupin Recent Developments

Table 146. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Company Information

Table 147. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Description and Major Businesses

Table 148. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 149. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 150. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Recent Developments

Table 151. General Factory Company Information

Table 152. General Factory Description and Major Businesses

Table 153. General Factory Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 154. General Factory Anti-erectile Dysfunction (ED) Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 155. General Factory Recent Developments

Table 156. CSBio Company Information

Table 157. CSBio Description and Major Businesses

Table 158. CSBio Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 159. CSBio Anti-erectile Dysfunction (ED) Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 160. CSBio Recent Developments

Table 161. Dong-A ST Company Information

Table 162. Dong-A ST Description and Major Businesses

Table 163. Dong-A ST Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 164. Dong-A ST Anti-erectile Dysfunction (ED) Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 165. Dong-A ST Recent Developments

Table 166. Metuchen Pharma Company Information

Table 167. Metuchen Pharma Description and Major Businesses

Table 168. Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 169. Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 170. Metuchen Pharma Recent Developments

Table 171. Seoul Pharma Company Information

Table 172. Seoul Pharma Description and Major Businesses

Table 173. Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 174. Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 175. Seoul Pharma Recent Developments

Table 176. Teva Pharma Company Information

Table 177. Teva Pharma Description and Major Businesses

Table 178. Teva Pharma Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 179. Teva Pharma Anti-erectile Dysfunction (ED) Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 180. Teva Pharma Recent Developments

Table 181. S.K. Chemicals Company Information

Table 182. S.K. Chemicals Description and Major Businesses

Table 183. S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 184. S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 185. S.K. Chemicals Recent Developments

Table 186. Key Raw Materials Lists

Table 187. Raw Materials Key Suppliers Lists

Table 188. Anti-erectile Dysfunction (ED) Drugs Distributors List

Table 189. Anti-erectile Dysfunction (ED) Drugs Customers List

Table 190. Anti-erectile Dysfunction (ED) Drugs Market Trends

Table 191. Anti-erectile Dysfunction (ED) Drugs Market Drivers

Table 192. Anti-erectile Dysfunction (ED) Drugs Market Challenges

Table 193. Anti-erectile Dysfunction (ED) Drugs Market Restraints

Table 194. Research Programs/Design for This Report

Table 195. Key Data Information from Secondary Sources

Table 196. Key Data Information from Primary Sources

List of Figures

Figure 1. Anti-erectile Dysfunction (ED) Drugs Product Picture

Figure 2. Global Anti-erectile Dysfunction (ED) Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Anti-erectile Dysfunction (ED) Drugs Market Share by Type in 2023 & 2030

Figure 4. Sildenafil (Viagra) Product Picture

Figure 5. Vardenafil (Levitra, Staxyn) Product Picture

Figure 6. Tadalafil (Cialis) Product Picture

Figure 7. Avanafil (Stendra) Product Picture

Figure 8. Udenafil (Zydena) Product Picture

Figure 9. Others Product Picture

Figure 10. Global Anti-erectile Dysfunction (ED) Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 11. Global Anti-erectile Dysfunction (ED) Drugs Market Share by Application in 2023 & 2030

Figure 12. Hospital

Figure 13. Retail Pharmacy

Figure 14. Clinic

Figure 15. Online Pharmacy

Figure 16. Anti-erectile Dysfunction (ED) Drugs Report Years Considered

Figure 17. Global Anti-erectile Dysfunction (ED) Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 18. Global Anti-erectile Dysfunction (ED) Drugs Revenue 2019-2030 (US$ Million)

Figure 19. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 20. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Region (2019-2030)

Figure 21. Global Anti-erectile Dysfunction (ED) Drugs Sales 2019-2030 ((K Units)

Figure 22. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Region (2019-2030)

Figure 23. US & Canada Anti-erectile Dysfunction (ED) Drugs Sales YoY (2019-2030) & (K Units)

Figure 24. US & Canada Anti-erectile Dysfunction (ED) Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 25. Europe Anti-erectile Dysfunction (ED) Drugs Sales YoY (2019-2030) & (K Units)

Figure 26. Europe Anti-erectile Dysfunction (ED) Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 27. China Anti-erectile Dysfunction (ED) Drugs Sales YoY (2019-2030) & (K Units)

Figure 28. China Anti-erectile Dysfunction (ED) Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 29. Asia (excluding China) Anti-erectile Dysfunction (ED) Drugs Sales YoY (2019-2030) & (K Units)

Figure 30. Asia (excluding China) Anti-erectile Dysfunction (ED) Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 31. Middle East, Africa and Latin America Anti-erectile Dysfunction (ED) Drugs Sales YoY (2019-2030) & (K Units)

Figure 32. Middle East, Africa and Latin America Anti-erectile Dysfunction (ED) Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 33. The Anti-erectile Dysfunction (ED) Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 34. The Top 5 and 10 Largest Manufacturers of Anti-erectile Dysfunction (ED) Drugs in the World: Market Share by Anti-erectile Dysfunction (ED) Drugs Revenue in 2023

Figure 35. Global Anti-erectile Dysfunction (ED) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 36. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Type (2019-2030)

Figure 37. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Type (2019-2030)

Figure 38. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Application (2019-2030)

Figure 39. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Application (2019-2030)

Figure 40. US & Canada Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Type (2019-2030)

Figure 41. US & Canada Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Type (2019-2030)

Figure 42. US & Canada Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Application (2019-2030)

Figure 43. US & Canada Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Application (2019-2030)

Figure 44. US & Canada Anti-erectile Dysfunction (ED) Drugs Revenue Share by Country (2019-2030)

Figure 45. US & Canada Anti-erectile Dysfunction (ED) Drugs Sales Share by Country (2019-2030)

Figure 46. U.S. Anti-erectile Dysfunction (ED) Drugs Revenue (2019-2030) & (US$ Million)

Figure 47. Canada Anti-erectile Dysfunction (ED) Drugs Revenue (2019-2030) & (US$ Million)

Figure 48. Europe Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Type (2019-2030)

Figure 49. Europe Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Type (2019-2030)

Figure 50. Europe Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Application (2019-2030)

Figure 51. Europe Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Application (2019-2030)

Figure 52. Europe Anti-erectile Dysfunction (ED) Drugs Revenue Share by Country (2019-2030)

Figure 53. Europe Anti-erectile Dysfunction (ED) Drugs Sales Share by Country (2019-2030)

Figure 54. Germany Anti-erectile Dysfunction (ED) Drugs Revenue (2019-2030) & (US$ Million)

Figure 55. France Anti-erectile Dysfunction (ED) Drugs Revenue (2019-2030) & (US$ Million)

Figure 56. U.K. Anti-erectile Dysfunction (ED) Drugs Revenue (2019-2030) & (US$ Million)

Figure 57. Italy Anti-erectile Dysfunction (ED) Drugs Revenue (2019-2030) & (US$ Million)

Figure 58. Russia Anti-erectile Dysfunction (ED) Drugs Revenue (2019-2030) & (US$ Million)

Figure 59. China Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Type (2019-2030)

Figure 60. China Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Type (2019-2030)

Figure 61. China Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Application (2019-2030)

Figure 62. China Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Application (2019-2030)

Figure 63. Asia Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Type (2019-2030)

Figure 64. Asia Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Type (2019-2030)

Figure 65. Asia Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Application (2019-2030)

Figure 66. Asia Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Application (2019-2030)

Figure 67. Asia Anti-erectile Dysfunction (ED) Drugs Revenue Share by Region (2019-2030)

Figure 68. Asia Anti-erectile Dysfunction (ED) Drugs Sales Share by Region (2019-2030)

Figure 69. Japan Anti-erectile Dysfunction (ED) Drugs Revenue (2019-2030) & (US$ Million)

Figure 70. South Korea Anti-erectile Dysfunction (ED) Drugs Revenue (2019-2030) & (US$ Million)

Figure 71. China Taiwan Anti-erectile Dysfunction (ED) Drugs Revenue (2019-2030) & (US$ Million)

Figure 72. Southeast Asia Anti-erectile Dysfunction (ED) Drugs Revenue (2019-2030) & (US$ Million)

Figure 73. India Anti-erectile Dysfunction (ED) Drugs Revenue (2019-2030) & (US$ Million)

Figure 74. Middle East, Africa and Latin America Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Type (2019-2030)

Figure 75. Middle East, Africa and Latin America Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Type (2019-2030)

Figure 76. Middle East, Africa and Latin America Anti-erectile Dysfunction (ED) Drugs Sales Market Share by Application (2019-2030)

Figure 77. Middle East, Africa and Latin America Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Application (2019-2030)

Figure 78. Middle East, Africa and Latin America Anti-erectile Dysfunction (ED) Drugs Revenue Share by Country (2019-2030)

Figure 79. Middle East, Africa and Latin America Anti-erectile Dysfunction (ED) Drugs Sales Share by Country (2019-2030)

Figure 80. Brazil Anti-erectile Dysfunction (ED) Drugs Revenue (2019-2030) & (US$ Million)

Figure 81. Mexico Anti-erectile Dysfunction (ED) Drugs Revenue (2019-2030) & (US$ Million)

Figure 82. Turkey Anti-erectile Dysfunction (ED) Drugs Revenue (2019-2030) & (US$ Million)

Figure 83. Israel Anti-erectile Dysfunction (ED) Drugs Revenue (2019-2030) & (US$ Million)

Figure 84. GCC Countries Anti-erectile Dysfunction (ED) Drugs Revenue (2019-2030) & (US$ Million)

Figure 85. Anti-erectile Dysfunction (ED) Drugs Value Chain

Figure 86. Anti-erectile Dysfunction (ED) Drugs Production Process

Figure 87. Channels of Distribution

Figure 88. Distributors Profiles

Figure 89. Bottom-up and Top-down Approaches for This Report

Figure 90. Data Triangulation

Figure 91. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions